Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Copper Cu-64 Dotatate
2. Copper Oxodotreotide Cu-64
3. Dotatate
1. Copper Cu 64 Dotatate
2. Copper 64-dota-tate
3. Copper Cu-64 Dotatate
4. N3858377kc
5. 1426155-87-4
6. Copper (64cu) Oxodotreotide
7. Unii-n3858377kc
8. Dtxsid901336538
9. Cuprate(2-)-64cu, (n-(2-(4,10-bis((carboxy-kappao)methyl)-7-(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl-kappan1,kappan4,kappan7,kappan10)acetyl)-d-phenylalanyl-l-cysteinyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-threonyl-l-cysteinyl-l-threoni
Molecular Weight | 1497.5 g/mol |
---|---|
Molecular Formula | C65H88CuN14O19S2 |
Hydrogen Bond Donor Count | 15 |
Hydrogen Bond Acceptor Count | 26 |
Rotatable Bond Count | 24 |
Exact Mass | 1496.508923 g/mol |
Monoisotopic Mass | 1496.508923 g/mol |
Topological Polar Surface Area | 554 Ų |
Heavy Atom Count | 101 |
Formal Charge | 0 |
Complexity | 2730 |
Isotope Atom Count | 1 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Copper Cu 64 Dotatate is a radiopharmaceutical used with positron emission tomography(PET) to locate somatostatin receptor-positive neuroendocrine tumors.
Absorption
Radioactivity can be identified in the kidney, liver, adrenal glands, spleen, and pituitary glands 1-3 hours after copper Cu 64 dotatate is administered.
Route of Elimination
16% - 40% of the original radioactivity was detected in urine 6 hours after the intravenous administration of a single dose.
The half-life of Copper Cu 64 is 12.7 hours.
The main target of the positron-emitting Copper Cu 64 dotatate is somatostatin receptor type 2 (SSTR2). SSTR2 is frequently overexpressed in malignant neuroendocrine cells; therefore, accumulation of the radionuclide at the site permits PET imaging to occur.
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Copper Cu-64 Dotatate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Copper Cu-64 Dotatate, including repackagers and relabelers. The FDA regulates Copper Cu-64 Dotatate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Copper Cu-64 Dotatate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Copper Cu-64 Dotatate supplier is an individual or a company that provides Copper Cu-64 Dotatate active pharmaceutical ingredient (API) or Copper Cu-64 Dotatate finished formulations upon request. The Copper Cu-64 Dotatate suppliers may include Copper Cu-64 Dotatate API manufacturers, exporters, distributors and traders.
click here to find a list of Copper Cu-64 Dotatate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Copper Cu-64 Dotatate DMF (Drug Master File) is a document detailing the whole manufacturing process of Copper Cu-64 Dotatate active pharmaceutical ingredient (API) in detail. Different forms of Copper Cu-64 Dotatate DMFs exist exist since differing nations have different regulations, such as Copper Cu-64 Dotatate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Copper Cu-64 Dotatate DMF submitted to regulatory agencies in the US is known as a USDMF. Copper Cu-64 Dotatate USDMF includes data on Copper Cu-64 Dotatate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Copper Cu-64 Dotatate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Copper Cu-64 Dotatate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Copper Cu-64 Dotatate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Copper Cu-64 Dotatate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Copper Cu-64 Dotatate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Copper Cu-64 Dotatate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Copper Cu-64 Dotatate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Copper Cu-64 Dotatate suppliers with NDC on PharmaCompass.
Copper Cu-64 Dotatate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Copper Cu-64 Dotatate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Copper Cu-64 Dotatate GMP manufacturer or Copper Cu-64 Dotatate GMP API supplier for your needs.
A Copper Cu-64 Dotatate CoA (Certificate of Analysis) is a formal document that attests to Copper Cu-64 Dotatate's compliance with Copper Cu-64 Dotatate specifications and serves as a tool for batch-level quality control.
Copper Cu-64 Dotatate CoA mostly includes findings from lab analyses of a specific batch. For each Copper Cu-64 Dotatate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Copper Cu-64 Dotatate may be tested according to a variety of international standards, such as European Pharmacopoeia (Copper Cu-64 Dotatate EP), Copper Cu-64 Dotatate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Copper Cu-64 Dotatate USP).
LOOKING FOR A SUPPLIER?